RankAlpha logo
Back to Rankings

MDWD

MediWoundF
Nasdaq / Pharmaceuticals, Biotechnology & Life Sciences
Last Price
Quote time unavailable
View Chart

Operating peers and competitors

Source-backed product markets and frozen research comparisons. Valuation comparators remain in the existing peer table.

Loading market evidence...

Research comparisons do not establish forecast usefulness or trading returns.

Compare shared product markets

Membership only; no portfolio weights or estimated losses.

+
Peers tracked
8
U.S. public peers
Grade Position
Below peers
vs peer average
MDWD vs peer average
34/100
MDWD vs. peer average (F vs. D)
Grade spread
B 1 · C 1 · D 3 · F 3
Graded peers loaded
Coverage
8 graded
100% of tracked

Peer overview

STRO is the first available peer comparator.

Same sector: Pharmaceuticals, Biotechnology & Life Sciences · Cap $154.7M

✓Peer source comes from the stored AI memo or peer model
✓Grades and factor rows use RankAlpha API data when available
✓Missing peer scores remain blank instead of being estimated
✓Side-by-side comparison keeps the data contract visible
Top peerSTROSutro Biopharma
MDWD
MediWound
STRO
Sutro Biopharma
Grade
F
D
Momentum
36
2
Value
41
41
Sentiment
-
64
Setup Bias
Net —
-
Market Cap
-
-
Posture
Defensive
Defensive

Grade position vs STRO

MDWD / STRO
Grade Position
Below peers
MDWD vs. peer average (F vs. D)
34/100
Momentum
36
MDWD
Value
41
MDWD
Sentiment
-
-

Rotation landscape

Peers ranked by the order returned from the peer source, with grades from the API.

Rank
Ticker
Company
Grade
Grade score
vs MDWD
1
STRO
Sutro Biopharma Inc Common
D
40/100
+1
2
NGEN
NervGen Pharma Corp Common
F
20/100
Even
3
CHRS
Coherus Oncology Inc Common
F
20/100
Even
4
AKBA
Akebia Therapeutics Inc Common
B
80/100
+3
5
NBP
NovaBridge Biosciences ADR
C
60/100
+2
STRO is the first peer returned for this comparison set.